Australia leading world in medicines Code, claims trade group

9 September 2012

Australia is a world leader in pharmaceutical industry conduct, and will continue to work towards further transparency of industry’s interactions with health care professionals, pharma trade group Medicines Australia’s chief executive Brendan Shaw said last week.

Responding to the implementation of the new expanded International Federation of Pharmaceutical Manufacturers and Associations’ Code of Practice, Dr Shaw said Australian consumers can be confident that the standards of ethical conduct and transparency demanded by the Medicines Australia Code of Conduct far exceed those of other countries.

“The expanded global Code is a positive step forward. It articulates high-level principles that hold companies to a high standard of ethical conduct,” Dr Shaw said, adding: “It also imposes new requirements that have been in place in Australia for many years, such as banning personal gifts and the provision of entertainment at educational events.”

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight



More Features in Pharmaceutical